Lexagene Holdings (TSXV:LXG.H) Gross Profit : C$-0.85 Mil (TTM As of Nov. 2022)

View and export this data going back to 2007. Start your Free Trial

What is Lexagene Holdings Gross Profit?

Lexagene Holdings's gross profit for the three months ended in Nov. 2022 was C$-0.20 Mil. Lexagene Holdings's gross profit for the trailing twelve months (TTM) ended in Nov. 2022 was C$-0.85 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Lexagene Holdings's gross profit for the three months ended in Nov. 2022 was C$-0.20 Mil. Lexagene Holdings's Revenue for the three months ended in Nov. 2022 was C$0.06 Mil. Therefore, Lexagene Holdings's Gross Margin % for the quarter that ended in Nov. 2022 was -341.38%.

Lexagene Holdings had a gross margin of -341.38% for the quarter that ended in Nov. 2022 => No sustainable competitive advantage

Lexagene Holdings Gross Profit Historical Data

The historical data trend for Lexagene Holdings's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lexagene Holdings Gross Profit Chart

Lexagene Holdings Annual Data

Trend

Mar13

Mar14

Mar15

Feb16

Feb17

Feb18

Feb19

Feb20

Feb21

Feb22

Gross Profit

Get a 7-Day Free Trial

-0.13

-0.60

Lexagene Holdings Quarterly Data
	Feb18	May18	Aug18	Nov18	Feb19	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22
Gross Profit	Get a 7-Day Free Trial															-0.13	-0.23	-0.18	-0.24	-0.20

Competitive Comparison of Lexagene Holdings's Gross Profit

For the Medical Devices subindustry, Lexagene Holdings's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Lexagene Holdings's Gross Profit Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Lexagene Holdings's Gross Profit distribution charts can be found below:

* The bar in red indicates where Lexagene Holdings's Gross Profit falls into.

Lexagene Holdings Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Lexagene Holdings's Gross Profit for the fiscal year that ended in Feb. 2022 is calculated as

Gross Profit (A: Feb. 2022 )	=	Revenue	-	Cost of Goods Sold
	=	0.095	-	0.69
	=	-0.60

Lexagene Holdings's Gross Profit for the quarter that ended in Nov. 2022 is calculated as

Gross Profit (Q: Nov. 2022 )	=	Revenue	-	Cost of Goods Sold
	=	0.058	-	0.256
	=	-0.20

Gross Profit for the trailing twelve months (TTM) ended in Nov. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.85 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

Lexagene Holdings's Gross Margin % for the quarter that ended in Nov. 2022 is calculated as

Gross Margin % (Q: Nov. 2022 )	=	Gross Profit (Q: Nov. 2022 )	/	Revenue (Q: Nov. 2022 )
	=	(Revenue - Cost of Goods Sold)	/	Revenue
	=	-0.20	/	0.058
	=	-341.38 %

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.

Lexagene Holdings (TSXV:LXG.H) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Lexagene Holdings had a gross margin of -341.38% for the quarter that ended in Nov. 2022 => No sustainable competitive advantage

Lexagene Holdings Gross Profit Related Terms

Thank you for viewing the detailed overview of Lexagene Holdings's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.

Lexagene Holdings (TSXV:LXG.H) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Lexagene Holdings Inc (TSXV:LXG.H) » Definitions » Gross Profit

Comparable Companies

Traded in Other Exchanges

N/A

Address

500 Cummings Center, Suite 4550, Beverly, MA, USA, 01915

Website

https://www.lexagene.com

Lexagene Holdings Inc is a molecular diagnostics company that develops molecular diagnostic systems for pathogen detection and genetic testing for other molecular markers for on-site rapid testing in veterinary diagnostics, and for use in open-access markets such as food and water safety, clinical research, agricultural testing and biodefense. The MiQLab system delivers sensitivity, specificity, and breadth of detection and can return results in approximately two hours. The unique open-access feature is designed for custom testing so that end-users can load their own real-time PCR assays onto the instrument to target any genetic target of interest.

Lexagene Holdings (TSXV:LXG.H) Headlines

No Headlines